BCRX

BioCryst Pharmaceuticals (BCRX)

About BioCryst Pharmaceuticals (BCRX)

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Details

Daily high

$9.66

Daily low

$9.23

Price at open

$9.50

52 Week High

$11.22

52 Week Low

$6.00

Market cap

2.4B

Dividend yield

0.00%

Volume

4.4M

Avg. volume

3.3M

P/E ratio

-6.18

BioCryst Pharmaceuticals News